Axogen Q3 net income more than triples to $2.33 million; revenue rises 26% to $75.83 million
AXGN•Axogen's third-quarter 2026 net income more than tripled year over year to $2.33 million, while revenue rose 26% to $75.83 million. The company expects full-year revenue of at least $290 million, including at least $7 million from BioCircuit Technologies.
1. Quarterly results and outlook
Axogen reported third-quarter 2026 net income of $2.33 million, more than triple the year-earlier figure, and revenue of $75.83 million, up 26% year over year. Its full-year 2026 revenue guidance calls for at least $290 million, including at least $7 million from BioCircuit Technologies, whose acquisition closed October 1.
